BeOne Medicines (ONC) Research & Development: 2015-2025
Historic Research & Development for BeOne Medicines (ONC) over the last 11 years, with Sep 2025 value amounting to $523.7 million.
- BeOne Medicines' Research & Development rose 5.54% to $523.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 8.77%. This contributed to the annual value of $2.0 billion for FY2024, which is 9.82% up from last year.
- BeOne Medicines' Research & Development amounted to $523.7 million in Q3 2025, which was down 0.24% from $524.9 million recorded in Q2 2025.
- BeOne Medicines' 5-year Research & Development high stood at $542.0 million for Q4 2024, and its period low was -$556.3 million during Q4 2021.
- Moreover, its 3-year median value for Research & Development was $481.9 million (2025), whereas its average is $478.4 million.
- In the last 5 years, BeOne Medicines' Research & Development tumbled by 256.46% in 2021 and then spiked by 180.18% in 2022.
- BeOne Medicines' Research & Development (Quarterly) stood at -$556.3 million in 2021, then spiked by 180.18% to $446.0 million in 2022, then increased by 10.75% to $494.0 million in 2023, then rose by 9.72% to $542.0 million in 2024, then grew by 5.54% to $523.7 million in 2025.
- Its last three reported values are $523.7 million in Q3 2025, $524.9 million for Q2 2025, and $481.9 million during Q1 2025.